{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:50:52Z","timestamp":1771879852534,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jacc.2017.02.056","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T14:15:22Z","timestamp":1493648122000},"page":"2304-2313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus"],"prefix":"10.1016","volume":"69","author":[{"given":"Alexander C.","family":"Fanaroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan K.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Prather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.02.056_bib1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States, 2014. Available at: http:\/\/www.cdc.gov\/diabetes\/pubs\/statsreport14\/national-diabetes-report-web.pdf. Accessed November 18,\u00a02016."},{"key":"10.1016\/j.jacc.2017.02.056_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/clc.22488","article-title":"Angina in coronary artery disease patients with and without diabetes: US National Health and Nutrition Examination Survey 2001\u20132010","volume":"39","author":"Hui","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2017.02.056_bib3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.02.056_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.02.056_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ahj.2014.06.020","article-title":"Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c","volume":"168","author":"Arnold","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.02.056_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.115.019768","article-title":"Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial","volume":"133","author":"Alexander","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.02.056_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1060028016631757","article-title":"Ranolazine and its effects on hemoglobin A1C","volume":"50","author":"Greiner","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2017.02.056_bib8","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2337\/db13-1562","article-title":"Blockade of Na+ channels in pancreatic alpha-cells has antidiabetic effects","volume":"63","author":"Dhalla","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2017.02.056_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a\u00a0multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.02.056_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ahj.2013.08.004","article-title":"Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial","volume":"166","author":"Weisz","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.02.056_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/CIRCOUTCOMES.113.000752","article-title":"Comparison of the Seattle Angina Questionnaire with daily angina diary in the TERISA clinical trial","volume":"7","author":"Arnold","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.02.056_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/dc14-2629","article-title":"Effect of ranolazine monotherapy on glycemic control in subjects with type 2 diabetes","volume":"38","author":"Eckel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2017.02.056_bib13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","article-title":"Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.02.056_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.12629","article-title":"Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin","volume":"18","author":"Pettus","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2017.02.056_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehi495","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.02.056_bib16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.02.056_bib17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.02.056_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.02.056_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.02.056_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.110.176396","article-title":"Ranolazine increases beta-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice","volume":"337","author":"Ning","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2017.02.056_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-010-0557-8","article-title":"Effects of ranolazine on fatty acid transformation in the isolated perfused rat liver","volume":"345","author":"Mito","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacc.2017.02.056_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpdd.174","article-title":"Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus","volume":"121","author":"Zack","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jacc.2017.02.056_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect\u00a0of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.02.056_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2015.09.004","article-title":"Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients","volume":"243","author":"Moura","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2017.02.056_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1475-2840-12-165","article-title":"Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2017.02.056_bib26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.amjcard.2005.10.039","article-title":"Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus","volume":"97","author":"Ravipati","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.02.056_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1476-511X-13-89","article-title":"Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina","volume":"13","author":"Hong","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacc.2017.02.056_bib28","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.2337\/db13-0420","article-title":"Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart","volume":"62","author":"Lu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2017.02.056_bib29","series-title":"Ranexa [package insert]","year":"2015"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971736045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971736045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:13:41Z","timestamp":1760015621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971736045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S073510971736045X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.02.056","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.02.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}